Abstract:Abstract We present a rare diagnosis in a 41-year-old man referred urgently from the infectious diseases team with a 3-week history of extensive itchy and painful mucocutaneous blistering and ulceration. This initially affected his hands, spreading to involve his limbs and trunk. His oral and genital mucosae were similarly affected. He reported lethargy and weight loss secondary to reduced oral intake but was otherwise systemically well. He had hypertension managed with amlodipine but he had not recently taken any other medications or supplements. He had emigrated to the UK from Ghana 6 months earlier and no contacts were similarly affected. Examination revealed multiple tense vesicles and bullae with crusted erosions scattered across his trunk and limbs on a background of urticated erythema involving approximately 40% of his body surface area. Haemorrhagic bullae were present on his tongue, his labial and buccal mucosa, and his genital mucosa. He had an extensive infection screen. Of note, viral polymerase chain reaction of vesicular fluid was negative and he was noted to have negative varicella zoster virus (VZV) IgG, in keeping with his history of never previously having chickenpox. Histopathology demonstrated subepidermal blistering with neutrophils and a neutrophil-rich superficial perivascular inflammatory infiltrate and small collections of neutrophils in dermal papillae with incipient clefting. Direct immunofluorescence showed linear deposition of IgG and C3 along the basement membrane zone localizing to the base on salt-split skin. Enzyme-linked immunosorbent assay to collagen VII was strongly positive, and it was negative to BP180/230. On the basis of his clinical findings and investigation results, epidermolysis bullosa acquisita (EBA) was diagnosed. After careful consideration and discussion with the patient, the decision was made to delay systemic immunosuppressive treatment until he had completed VZV vaccination. He was initially managed with clobetasol ointment, Trimovate cream (clobetasone butyrate, nystatin and oxytetracycline calcium) and fluticasone mouthwash. He subsequently commenced prednisolone 40 mg daily, with complete resolution of blistering within 1 month, leaving areas of postinflammatory hypopigmentation, scarring and milia. The introduction of dapsone 50 mg daily has enabled him to gradually wean the dose of prednisolone without further flares. EBA is a very rare immunobullous disease characterized by autoantibodies directed against collagen VII. Different clinical phenotypes are recognized, including a mechanobullous phenotype characterized by acral involvement, skin fragility, scarring and milia; an inflammatory phenotype with skin changes resembling pemphigoid; and a mucosal dominant phenotype. His case was complicated by the need to delay systemic immunosuppression to enable VZV vaccination, an important consideration when long-term immunosuppression may be required. Fortunately, our patient has shown an excellent response to dapsone, highlighting the value of this medication in EBA, among other immunobullous diseases.

BI38 A rare case of acquired epidermodysplasia verruciformis

Poster presentationsDP11 Bright, eosinophilic intracytoplasmic inclusion bodies: a rare presentation of acquired epidermodysplasia verruciformis with widespread human papillomavirus infection in a transplant recipient

[Acquired Epidermodysplasia Verruciformis in a Renal Transplant Patient: Case Report and Literature Review]

BI30 An extensive follicular eruption in a transplant recipient

Eyelid Squamous Cell Carcinoma in the Setting of Epidermodysplasia Verruciformis (EV) Diagnosed by Next-Generation Sequencing: A Case Report and Literature Review.

Epidermodysplasia Verruciformis (Lewandowsky and Lutz's Dysplasia)

Epidermodysplasia verruciformis–associated eccrine neoplasm: a rare entity with distinctive clinical and histopathologic features

Successful Treatment of Epidermodysplasia Verruciformis with a Combination of 5-Aminolevulinic Acid Photodynamic Therapy and Surgery.

Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review

Autosomal –dominant epidermodysplasia verruciformisun satisfactorily treated with ingenol mebutate: a case report

DP15 A rare immunobullous diagnosis in a varicella zoster-naive patient

Synchronous Epidermodysplasia Verruciformis and Intraepithelial Lesion of the Vulva Is Caused by Coinfection With Alpha-Human Papillomavirus and Beta-Human Papillomavirus Genotypes and Facilitated by Mutations in Cell-Mediated Immunity Genes

P04 Leg ulceration in a patient with antisynthetase syndrome

Identification of LCK Mutation in a Family with Atypical Epidermodysplasia Verruciformis with T-cell Defects and Virus-Induced Squamous Cell Carcinoma.

Epidermal nevi and epidermolytic hyperkeratosis: A review of cases, highlighting indications for biopsy and genetics referral

Asymptomatic evanescent plaques on the buttocks of an elderly woman

Case Report of Two Independent Moroccan Families with Syndromic Epidermodysplasia Verruciformis and STK4 Deficiency

[Primary cutaneous aggressive epidermotropic cytotoxic CD8 positive T cell lymphoma: report of one case]

Multifocal Epstein-Barr Virus-Positive Mucocutaneous Ulcers in a Patient With Crohn's Disease

A woman with mycosis fungoides, vitiligo, and a new hand nodule

Delayed Complete Clearance of Recalcitrant Warts Due to Intralesional Measles, Mumps, and Rubella: Case Report and Review